FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Fast Track for AC Immune Alzheimers Drug

[ Price : $8.95]

FDA grants fast-track designation to AC Immunes investigational candidate being developed with Janssen for Alzheimers disease.

Shuren Retiring; Tarver is Acting CDRH Director

[ Price : $8.95]

CDRH director Jeff Shuren says he is retiring later this year and deputy Center director for transformation Michelle Tarver will s...

FDA Wants Host Cell Protein Immunogenicity Info

[ Price : $8.95]

FDA establishes a docket for information and comments on evaluating and mitigating the immunogenicity risk of host cell proteins.

Biocon Biosphere FDA-483

[ Price : $8.95]

FDA releases the form FDA-483 with three observations from an inspection at Biocon Biosphere in Andhra Pradesh, India.

Pfizer Optimistic on Hemphilia A Gene Therapy

[ Price : $8.95]

Pfizer plans to discuss with FDA its path to seek approval of its investigational gene therapy for treating adults with moderately...

Mesa Bio Covid Test Authorization Revoked

[ Price : $8.95]

Federal Register notice: FDA announces that it revoked a Mesa Biotech emergency use authorization for the Accula SARS-CoV-2 Test.

FDA Seeks Input on Biosimilar Guidance Development

[ Price : $8.95]

FDA establishes a docket to receive information and comments on how best to advance the development of new biosimilar biological p...

RWD in Regulatory Decisions Guidance

[ Price : $8.95]

FDA publishes a guidance on assessing types of medical records to provide real-world data (RWD) for drugs and biologics regulatory...

Glass Vial, Stopper Guidance

[ Price : $8.95]

FDA publishes a guidance with recommendations for reporting categories and the content of postapproval change submissions about gl...

Common BIMO Violations Listed

[ Price : $8.95]

Attorney Julie Tibbets reviews the Warning Letters issued in FY 2023 and so far in FY 2024 under the FDA Bioresearch Monitoring pr...